Adaptimmune Therapeutics plc

NasdaqGS:ADAP Stock Report

Market Cap: US$178.4m

Adaptimmune Therapeutics plc Company Information

Adaptimmune Therapeutics plc's employee growth, exchange listings and data sources

Key Information

  • Name: Adaptimmune Therapeutics plc
  • Ticker: ADAP
  • Exchange: NasdaqGS
  • Founded: 2008
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$178.376m
  • Shares Outstanding: 255.88m
  • Website: https://www.adaptimmune.com

Number of Employees

Location

  • Adaptimmune Therapeutics plc
  • 60 Jubilee Avenue
  • Milton Park
  • Abingdon
  • Oxfordshire
  • OX14 4RX
  • United Kingdom

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ADAPNasdaqGS (Nasdaq Global Select)YesADS EACH REPR ORD SHS (SPONS)USUSDMay 2015
473ADB (Deutsche Boerse AG)YesADS EACH REPR ORD SHS (SPONS)DEEURMay 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/26 13:15
End of Day Share Price 2024/11/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.